Ehab Darwish | Host Genetics | Best Researcher Award

Dr. Ehab Darwish | Host Genetics | Best Researcher Award

Author Profile

Scopus

Orcid ID

Faculty of Medicine, King Faisal University | Saudi Arabia

Biography of Dr. Ehab Mohamed Ibrahim Darwish: A Pioneer in Tropical Medicine, Gastroenterology, and Infectious Diseases šŸŒ

EARLY ACADEMIC PURSUITS šŸŽ“

Dr. Ehab Mohamed Ibrahim Darwish embarked on his medical journey at Zagazig University, Egypt, where he earned his M.B., B.Ch. in Medicine in 1999. Driven by a passion for advancing his expertise in health sciences, Dr. Darwish pursued a Masterā€™s degree in Tropical Medicine in 2004, followed by a Doctorate in Tropical Medicine in 2009. These foundational years shaped his deep interest in infectious diseases, hepatology, and gastroenterology, setting the stage for a dedicated career in medicine and research.

PROFESSIONAL ENDEAVORS šŸ„

Dr. Darwish has held prestigious academic positions, including his role as an Assistant Professor of Gastroenterology, Hepatology & Infectious Diseases at Zagazig University. In June 2015, he joined King Faisal University in Saudi Arabia, where he currently serves as an Assistant Professor in the Department of Internal Medicine at the College of Medicine. His international experience has enabled him to bring a wealth of knowledge to his students and to the broader medical community in Saudi Arabia.

CONTRIBUTIONS AND RESEARCH FOCUS ON HOST GENETICS šŸ“Š

Throughout his career, Dr. Darwish has actively contributed to research in infectious diseases, hepatology, and gastroenterology. He has published numerous studies, several of which appear in Scopus-indexed and Web of Science journals. His research often addresses genetic factors in infectious diseases, an area where he has made impactful discoveries that are critical to understanding disease susceptibility and treatment response. Dr. Darwish's research accomplishments include 17 completed projects and 3 ongoing research initiatives, marking him as a prolific contributor to medical science.

IMPACT AND INFLUENCE šŸŒŸ

With a Scopus H-index of 3 and 61 citations, Dr. Darwishā€™s work has been recognized for its contributions to the fields of tropical medicine and infectious diseases. His research has provided essential insights into the prevention and treatment of various gastrointestinal and liver-related illnesses. Through both his teaching and research, he has influenced medical students and peers alike, emphasizing the importance of scientific inquiry in clinical practice.

ACADEMIC CITATIONS šŸ“ˆ

Dr. Darwishā€™s publications include six research articles in SCI and Scopus-indexed journals, underscoring his commitment to producing high-quality, peer-reviewed research. His work is frequently cited, reflecting his influence in tropical medicine and internal medicine. His dedication to understanding the genetic basis of infectious diseases has added a valuable dimension to his research, enhancing its applicability in both clinical and research settings.

LEGACY AND FUTURE CONTRIBUTIONS šŸŒ

Looking forward, Dr. Darwish aims to expand his research on genetics in infectious diseases, with plans to contribute to advancements in personalized medicine. His legacy is marked by his commitment to bridging clinical practice with research, fostering a generation of medical professionals trained in both the practical and theoretical aspects of medicine. Through continued collaborations, publications, and mentorship, Dr. Darwish is set to make lasting contributions to the global medical community.

OTHER SIGNIFICANT TOPICS AND PROFESSIONAL HIGHLIGHTS šŸ†

  • Areas of Research: Dr. Darwishā€™s expertise spans infectious diseases, hepatology, and gastroenterology, focusing on improving patient outcomes in these critical areas.
  • Completed and Ongoing Research Projects: With 17 completed and 3 ongoing projects, Dr. Darwish has maintained a productive and impactful research portfolio.
  • Professional Memberships and Collaborations: His involvement in professional networks and collaborations has strengthened his contributions and broadened the scope of his research.

NOTABLE PUBLICATIONSĀ šŸ“‘

"Value of Serum miRNA-96-5p and miRNA-99a-5p as Diagnostic Biomarkers for Hepatocellular Carcinoma, "Ā 

  • Authors: Gharib, A.F., , Eed, E.M., Khalifa, A.S., Darwiesh, E., Essa, A.,
  • Journal: International Journal of General Medicine
  • Year: 2022

"BAR Score Performance in Predicting Survival after Living Donor Liver Transplantation: A Single-Center Retrospective Study "Ā 

  • Authors: Zakareya, T. , Taha, M. , Elzohry, H. ,Deif, M. , Abbasy, M.
  • Journal: Ā Canadian Journal of Gastroenterology and Hepatology
  • Year: 2022

"Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections "Ā 

  • Authors: Abdel-Hamed, E.F. , Ibrahim, M.N. , Mostafa, N.E. , Al-Khoufi, E.A. , Hindawi, S.I.
  • Journal: Gut Pathogens
  • Year: 2021

"Endoscopic removal of foreign bodies from the upper gastrointestinal tract: 5-year experience"Ā 

  • Authors: Emara, M.H. , Darwiesh, E.M. , Refaey, M.M. , Galal, S.M.
  • Journal: Clinical and Experimental Gastroenterology
  • Year: 2014

"Endoscopic injection of autologous blood versus diluted epinephrine for control of actively bleeding gastroduodenal ulcers: A randomized-controlled study"Ā 

  • Authors: Emara, M.H. , Darwiesh, E.M. , Bihery, A.S. , Zaher, T.I.
  • Journal: European Journal of Gastroenterology and Hepatology
  • Year: 2014

Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher AwardĀ 

Dr. Giulia Pascolini | Neurodevelopmental Disorders | Best Researcher AwardĀ 

Dermopathic Institute of the Immaculate, IDI-IRCC | ItalyĀ 

Author Profile

ScopusĀ 

Orcid ID

Google Scholar

šŸŒŸ Biography of Giulia Pascolini, MD, PhD

šŸŽ“ EARLY ACADEMIC PURSUITS

Giulia Pascolini's journey in medical science began with a Degree in Medicine from Sapienza University of Rome in 2008, which she completed with honors. Following this, she pursued specialization in Medical Genetics at Tor Vergata University of Rome, graduating with honors in 2015 after five years of in-depth study. Driven by her passion for genetics, Dr. Pascolini went on to earn her Ph.D. in Medical Genetics from Sapienza University in 2019, establishing her expertise in a rapidly advancing field. In 2022, she further expanded her knowledge with a Master of II level in Rare Diseases, also from Sapienza University, solidifying her role as a leading expert in rare genetic disorders.

šŸ©ŗ PROFESSIONAL ENDEAVORS

Dr. Pascolini's professional career is marked by extensive experience across multiple prestigious institutions. Currently, she is a Clinical Geneticist and head of the Clinical Genetics Service at the Istituto Dermopatico dell'Immacolata (IDI-IRCCS) in Rome, Italy. Since September 2023, she also holds a position as Professor of Medical Genetics at the Faculty of Medicine and Surgery at Tor Vergata University of Rome. Over the years, she has held various roles, including serving as a clinical geneticist at Bambino GesĆ¹ Childrenā€™s Hospital and a researcher at San Camillo-Forlanini Hospital. Her long-standing commitment to clinical genetics spans over 15 years, with a focus on intellectual disability syndromes, dysmorphology, and developmental disorders.

šŸ”¬ CONTRIBUTIONS AND RESEARCH FOCUS ON NEURODEVELOPMENTAL DISORDERSĀ 

Dr. Pascolini's research primarily centers around Developmental Disorders of Chromatin Remodeling (DDCRs), intellectual disability (ID) syndromes, and genodermatoses. She has played a crucial role in the study of the skin phenotype in rare genetic diseases, and her work on deep learning technologies for diagnosing genetic syndromes using facial phenotype recognition is groundbreaking. Her involvement with FDNA Inc. and the DeepGestalt technology is a testament to her contributions to advancing medical genetics through innovative platforms. She is also a principal investigator for multiple research projects, including studies on rare cutaneous tumors and familial melanoma, with funding of over ā‚¬47,000 for these projects.

šŸŒ IMPACT AND INFLUENCE

As a Scientific Board Member of the ADNP Syndrome Italian Association and an editorial board member of the Journal of Pediatric Genetics, Dr. Pascolini has made significant contributions to the broader medical community. Her work has helped shape new approaches to the clinical understanding of complex genetic disorders, particularly in rare diseases and neurodevelopmental syndromes. Through her collaborative efforts with international organizations and her academic roles, she continues to influence both current medical practices and future research directions.

šŸ“š ACADEMIC CITES AND PUBLICATIONS

Dr. Pascolini has authored several impactful works, including her involvement in the DeepGestalt technology article on SETD5-associated intellectual disability published in the Journal of Translational Genetics and Genomics. Her contributions to book chapters, such as her writing on Genomic Copy Number Variants (CNVs) and Autism Spectrum Disorder (ASD), have added substantial value to academic literature. Her expertise has also been recognized through invitations to write for special issues in leading journals, enhancing her standing as a key voice in her field.

šŸ… AWARDS AND RECOGNITION

In 2019, Dr. Pascolini was awarded the Franca Dagna Bricarelli Award for her clinical research on genetic mutations associated with the BAF complex. This prestigious award highlights her excellence in medical genetics and clinical research. Her contributions to the field, recognized by peers and institutions alike, reflect her profound impact on the study and treatment of genetic disorders.

šŸŒŸ LEGACY AND FUTURE CONTRIBUTIONS

With her leadership in clinical genetics, active research on rare skin diseases, and innovative work in genetic syndrome diagnostics, Dr. Pascolini is poised to continue shaping the future of medical genetics. Her contributions to understanding the genetic basis of intellectual disabilities and her work on cutting-edge diagnostic technologies ensure her legacy as a pioneering figure in genetics. As she continues her role in both clinical and academic settings, her future contributions will likely further advance the study and treatment of rare genetic conditions, helping countless individuals worldwide.

šŸ“‘NOTABLE PUBLICATIONSĀ 

"The face of Non-photosensitive trichothiodystrophy phenotypic spectrum: A subsequent study on paediatric population"Ā 

  • Authors: Pascolini, G. , Lipari, M. , Gaudioso, F. , Di Zenzo, G. , Didona, B.
  • Journal: Molecular Genetics and Genomic Medicine
  • Year: 2024

"Usmani-Riazuddin syndrome can have a recognizable phenotype: Report of a novel AP1G1 variant"Ā 

  • Authors: Gnazzo, M. , Pascolini, G. , Parlapiano, G. , Novelli, A. , Baban, A.
  • Journal: Clinical Genetics
  • Year: 2024

"Extended phenotypic characterization of a novel Helsmoortel-van der Aa syndrome case series"Ā 

  • Authors: Pascolini, G., Di Zenzo, G., Panebianco, A., Didona, B., Gozes, I.
  • Journal: American Journal of Medical Genetics
  • Year: 2024

"Ectoderm-derived findings in AymĆØ-Gripp syndrome"Ā 

  • Authors: Pascolini, G., Di Zenzo, G., Morani, P., Didona, B., Panebianco, A.
  • Journal: Journal of Dermatology
  • Year: 2024

"Defining the clinical spectrum of ichthyosis follicularis, atrichia and photophobia clinical association type 1 (IFAP1)"Ā 

  • Authors: Pascolini, G., Fortugno, P., Chandramouli, B., Didona, B., Castiglia, D.
  • Journal: European Journal of Dermatology
  • Year: 2023

Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Prof Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States

Author Profile

Scopus

Early Academic Pursuits

Qing Richard Lu embarked on his academic journey with a Bachelor of Science in Biochemistry from Peking Normal University in Beijing, China, which he completed in 1988. Following this, he pursued a Master of Science in Biophysics at Rutgers University, New Jersey, USA, completing his degree in 1993. He continued his studies at Rutgers University, earning a Ph.D. in Biochemistry in 1997 under the mentorship of Dr. Masayori Inouye.

Professional Endeavors

Dr. Lu's professional career began with a postdoctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School, from 1997 to 2002. He worked with Dr. Chuck D. Stiles and collaborated with Dr. David Rowitch. In 2002, he joined the UT Southwestern Medical Center as an Assistant Professor in the Department of Developmental Biology, where he held the position of Southwestern Medical Foundation Endowed Scholar in Medical Research. He was promoted to Associate Professor with tenure in 2009 and continued in this role until 2013.Ā In 2013, Dr. Lu joined Cincinnati Childrenā€™s Hospital Medical Center and the University of Cincinnati College of Medicine. He currently holds the position of Professor with tenure in the Department of Pediatrics. Additionally, he serves as the Scientific Director of the Brain Tumor Center and Program Leader of the Brain Tumor Program in the Division of Experimental Hematology and Cancer Biology, Cancer & Blood Diseases Institute.

Contributions and Research Focus on Neurodegenerative Diseases

Dr. Lu's research primarily focuses on the molecular and cellular mechanisms underlying brain tumors. His work is significant in understanding the biology of brain cancer and developing new therapeutic strategies. He has made notable contributions to the field of experimental hematology and cancer biology through his research on brain tumor development, progression, and treatment.

Impact and Influence

Throughout his career, Dr. Lu has influenced the field of pediatric oncology and neurobiology. His research has provided insights into the genetic and biochemical pathways involved in brain tumors, contributing to the development of novel therapeutic approaches. His work has been recognized through various academic appointments and endowed scholarships, reflecting his significant impact on medical research.

Academic Cites

Dr. Lu's work has been widely published in numerous scientific journals, and his research findings are frequently cited by peers in the field. His publications contribute to the broader scientific understanding of brain tumors and their treatment, solidifying his reputation as a leading expert in the field.

Legacy and Future Contributions

As a leading figure in pediatric oncology and neurobiology, Dr. Lu's legacy is marked by his commitment to advancing scientific knowledge and improving patient outcomes. His ongoing research efforts and leadership roles at Cincinnati Childrenā€™s Hospital Medical Center and the University of Cincinnati College of Medicine continue to shape the future of brain tumor research and treatment. Dr. Luā€™s future contributions are expected to further enhance the understanding and management of brain tumors, paving the way for innovative therapeutic solutions and improved patient care.

Notable PublicationsĀ